Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake

International Journal of Cardiology

Volumn 116, Issue 3, 2007, Pages

  Yalta, Kenan ^a   Turgut, Okan ^a   Yilmaz, Ahmet ^a   Yilmaz, M Birhan ^a   Kendirlioglu, Omer ^a   Karadas, Filiz ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

QT interval; Sotalol; Torsades de pointes

Indexed keywords

ATENOLOL; SOTALOL;

ADULT; ARTICLE; CASE REPORT; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; DIRECT CURRENT; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MISUSE; DRUG SENSITIVITY; ELECTRIC SHOCK; FEMALE; HEART PALPITATION; HUMAN; LOW DRUG DOSE; PRESYNCOPE; PRIORITY JOURNAL; QT PROLONGATION; RISK FACTOR; SYMPTOM; THORAX PAIN; TORSADE DES POINTES;

ADULT; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LONG QT SYNDROME; SOTALOL; TORSADES DE POINTES;

EID: 33847115788     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.08.091     Document Type: Article

References (11)

1. Cranefield P.F., and Aronson R.S. Torsade de pointes and other pause-induced ventricular tachycardias: the short-long-short sequence and early after depolarizations. Pacing Clin Electrophysiol 11 6 Pt 1 (1988) 670-678
2. Liu X.K., Katchman A., Drici M.D., et al. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther 285 (1998) 672-679
3. Abriel H., Schlapfer J., Keller D.I., et al. Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy. Swiss Med Wkly 134 (2004) 685-694
4. Antzelevitch C. Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem?. J Electrocardiol 37 (2004) 15-24 (Suppl)
5. Roden D.M. Pharmacogenetics and drug-induced arrhythmias. Cardiovasc Res 50 (2001) 224-231
6. Drici M.D., and Clement N. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 24 (2001) 575-585
7. Schulze-Bahr E., Haverkamp W., Eckardt L., Kirchhof P., Wedekind H., and Breithardt G. Genetic aspects in acquired long QT syndrome - a piece in the puzzle. Eur Heart J Suppl Supplement K (2001) K48-K52
8. Yang P., Kanki H., Drolet B., et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 105 (2002) 1943-1948
9. Donger C., Denjoy I., Berthet M., et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 96 (1997) 2778-2781
10. Aloia D., Faggiano A., Brentana P., et al. Sustained torsades de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease. Int J Cardiol 105 3 (2005) 337-339
11. Cammu G., Geelen P., Baetens P., De Vas J., and Demeyer I. Two cases of torsades de pointes caused by sotalol therapy. Resuscitation 40 1 (1999) 49-51